Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer To Adopt Pharmacia Marketing PR: Mergers Changing Publicity Skills

Executive Summary

Pfizer is preparing to adopt Pharmacia's approach of having a separate marketing PR group as a best practice program for the newly merged companies

You may also be interested in...



Schering Drug Licensing Division To Be Headed By Ex-Pharmacia Exec

Ex-Pharmacia exec Michael DuBois will head Schering-Plough's newly formed product licensing division

Schering Drug Licensing Division To Be Headed By Ex-Pharmacia Exec

Ex-Pharmacia exec Michael DuBois will head Schering-Plough's newly formed product licensing division

Pfizer Responds To “The Pink Sheet” On Partnerships

[The following is a copy of a Dec. 6 letter from Pfizer to "The Pink Sheet" objecting to coverage of a speech by CEO Hank McKinnell (1"The Pink Sheet" Dec. 2, p. 14). The article focused on the portion of McKinnell's remarks that covered potential trouble points for partnerships.]

Related Content

UsernamePublicRestriction

Register

PS041744

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel